KAYEXALATE

This brand name is authorized in Canada, France, Israel, Japan, Tunisia.

Active ingredients

The drug KAYEXALATE contains one active pharmaceutical ingredient (API):

1
UNII 1699G8679Z - SODIUM POLYSTYRENE SULFONATE
 
Read more about Polystyrene sulfonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AE01 Polystyrene sulfonate V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02026961
FR Base de données publique des médicaments 64360751, 65475361, 67499717
IL מִשְׂרַד הַבְּרִיאוּת 6263
JP 医薬品医療機器総合機構 2190009A1048, 2190009R1025
TN Direction de la Pharmacie et du Médicament 6593051H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈